A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Verloop, Willemien L ^a   Beeftink, Martine M A ^a   Santema, Bernadet T ^a   Bots, Michiel L ^a   Blankestijn, Peter J ^a   Cramer, Maarten J ^a   Doevendans, Pieter A ^a   Voskuil, Michiel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE;

ARTICLE; ECHOCARDIOGRAPHY; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART RATE VARIABILITY; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; NERVOUS SYSTEM FUNCTION; NONHUMAN; PRESSORECEPTOR REFLEX; SYMPATHETIC NERVE; SYMPATHETIC NERVE ACTIVATION; SYMPATHETIC TONE; SYSTEMATIC REVIEW; ADRENERGIC SYSTEM; ANIMAL; FACTUAL DATABASE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; META ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; DATABASES, FACTUAL; ECHOCARDIOGRAPHY; HEART FAILURE; HUMANS; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR FUNCTION, LEFT;

EID: 84922569400     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117332     Document Type: Article

References (73)

1. Mahadevan G, Dwivedi G, Williams L, Steeds RP, Frenneaux M. (2012) Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: Rationale and design of the study. Eur J Heart Fail 14: 106-112. doi: 10.1093/eurjhf/hfr153 PMID: 22120964
2. Mosterd A, Hoes AW. (2007) Clinical epidemiology of heart failure. Heart 93: 1137-1146. PMID: 17699180
3. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, et al. (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 14: 803-869. doi: 10.1093/eurjhf/hfs105 PMID: 22828712
4. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, et al. (2013) 2013 ACCF/AHA guideline for the management of heart failure: A report of the american college of cardiology Foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 62: e147-239. doi: 10.1016/j.jacc. 2013.05.019 PMID: 23747642
5. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, et al. (2007) How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the european society of cardiology. Eur Heart J 28: 2539-2550. PMID: 17428822
6. Borlaug BA, Paulus WJ. (2011) Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment. Eur Heart J 32: 670-679. doi: 10.1093/eurheartj/ehq426 PMID: 21138935
7. Daniel KR, Wells G, Stewart K, Moore B, Kitzman DW. (2009) Effect of aldosterone antagonism on exercise tolerance, doppler diastolic function, and quality of life in older women with diastolic heart failure. Congest Heart Fail 15: 68-74. doi: 10.1111/j.1751-7133.2009.00056.x PMID: 19379452
8. van Veldhuisen DJ, Cohen-Solal A, Bohm M, Anker SD, Babalis D, et al. (2009) Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data from SENIORS (study of effects of nebivolol intervention on outcomes and rehospitalization in seniors with heart failure). J Am Coll Cardiol 53: 2150-2158. doi: 10.1016/j.jacc.2009.02.046 PMID: 19497441
9. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, et al. (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-preserved trial. Lancet 362: 777-781. PMID: 13678871
10. Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, et al. (2013) Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: The aldo-DHF randomized controlled trial. JAMA 309: 781-791. doi: 10.1001/jama.2013.905 PMID: 23443441
11. van Kraaij DJ, van Pol PE, Ruiters AW, de Swart JB, Lips DJ, et al. (2002) Diagnosing diastolic heart failure. Eur J Heart Fail 4: 419-430. PMID: 12167379
12. Zile MR, Baicu CF, Gaasch WH. (2004) Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350: 1953-1959. PMID: 15128895
13. Zile MR, Brutsaert DL. (2002) New concepts in diastolic dysfunction and diastolic heart failure: Part II: Causal mechanisms and treatment. Circulation 105: 1503-1508. PMID: 11914262
14. Mandinov L, Eberli FR, Seiler C, Hess OM. (2000) Diastolic heart failure. Cardiovasc Res 45: 813-825. PMID: 10728407
15. Wachter R, Schmidt-Schweda S, Westermann D, Post H, Edelmann F, et al. (2009) Blunted frequencydependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. Eur Heart J 30: 3027-3036. doi: 10.1093/eurheartj/ehp341 PMID: 19720638
16. Hogg K, McMurray J. (2005) Neurohumoral pathways in heart failure with preserved systolic function. Prog Cardiovasc Dis 47: 357-366. PMID: 16115515
17. Wright JW, Mizutani S, Harding JW. (2008) Pathways involved in the transition from hypertension to hypertrophy to heart failure. treatment strategies. Heart Fail Rev 13: 367-375. PMID: 17987382
18. Cacciapuoti F. (2011) Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives. J Am Soc Hypertens 5: 449-455. doi: 10.1016/j.jash. 2011.08.006 PMID: 22015318
19. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, et al. (1995) Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92: 3206-3211. PMID: 7586305
20. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, et al. (1996) Cardiac sympathetic nerve function in congestive heart failure. Circulation 93: 1667-1676. PMID: 8653872
21. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 6:e1000100. doi: 10.1371/journal.pmed.1000100 PMID: 19621070
22. Esler M, Jennings G, Lambert G, Meredith I, Horne M, et al. (1990) Overflow of catecholamine neurotransmitters to the circulation: Source, fate, and functions. Physiol Rev 70: 963-985. PMID: 1977182
23. Vink EE, de Jager RL, Blankestijn PJ. (2013) Sympathetic hyperactivity in chronic kidney disease: Pathophysiology and (new) treatment options. Curr Hypertens Rep 15: 95-101. doi: 10.1007/s11906-013-0328-5 PMID: 23354877
24. Yuyama R, Yuasa F, Hikosaka M, Mimura J, Kawamura A, et al. (2005) Iodine 123-metaiodobenzylguanidine imaging reflect generalized sympathetic activation in patients with left ventricular dysfunction. Clin Physiol Funct Imaging 25: 34-39. PMID: 15659078
25. Hilz MJ, Dutsch M. (2006) Quantitative studies of autonomic function. Muscle Nerve 33: 6-20. PMID: 15965941
26. Brooks WW, Conrad CH. (2009) Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: Structural and functional correlates. Comp Med 59: 339-343. PMID: 19712573
27. Grimm D, Elsner D, Schunkert H, Pfeifer M, Griese D, et al. (1998) Development of heart failure following isoproterenol administration in the rat: Role of the renin-angiotensin system. Cardiovasc Res 37: 91-100. PMID: 9539862
28. Krishnamurthy P, Subramanian V, Singh M, Singh K. (2007) (Beta)1 integrins modulate (beta)-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Hypertension 49: 865-872 PMID: 17283249
29. LaCroix C, Freeling J, Giles A, Wess J, Li Y-. (2008) Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. Am J Physiol Heart Circ Physiol 294: H810-820. PMID: 18055517
30. Ma X, Song Y, Chen C, Fu Y, Shen Q, et al. (2011) Distinct actions of intermittent and sustained betaadrenoceptor stimulation on cardiac remodeling. Sci China Life Sci 54: 493-501. doi: 10.1007/s11427-011-4183-9 PMID: 21706409
31. Sumita Yoshikawa W, Nakamura K, Miura D, Shimizu J, Hashimoto K, et al. (2012) Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophied rat hearts induced by chronic beta-adrenergic stimulation. Circ J 77: 741-748. PMID: 23220799
32. Arora R, Krummerman A, Vijayaraman P, Rosengarten M, Suryadevara V, et al. (2004) Heart rate variability and diastolic heart failure. Pacing Clin Electrophysiol 27: 299-303. PMID: 15009853
33. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Arenare F, et al. (2009) Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension 53: 205-209 doi: 10.1161/HYPERTENSIONAHA.108.121467 PMID: 19124679
34. Hirono O, Kubota I, Minamihaba O, Fatema K, Kato S, et al. (2001) Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral beta2-adrenoceptor agonists. Am Heart J 142: E11-16. PMID: 11717622
35. Nixdorff U, de Mey C, Belz GG, Erbel R, Simon H, et al. (1997) Beta-adrenergic stimulation enhances left ventricular diastolic performance in normal subjects. J Cardiovasc Pharmacol 29: 476-484. PMID: 9156357
36. Piccirillo G, Germano G, Vitarelli A, Ragazzo M, di Carlo S, et al. (2006) Autonomic cardiovascular control and diastolic dysfunction in hypertensive subjects. Int J Cardiol 110: 160-166. PMID: 16051387
37. de Souza SB, Rocha JA, Cuoco MA, Guerra GM, Ferreira-Filho JC, et al. (2013) High muscle sympathetic nerve activity is associated with left ventricular dysfunction in treated hypertensive patients. Am J Hypertens 26: 912-917. doi: 10.1093/ajh/hpt032 PMID: 23475700
38. Sugiura M, Yamamoto K, Takeda Y, Takeda Y, Dohmori T, et al. (2006) The relationship between variables of 123-I-metaiodobenzylguanidine cardiac imaging and clinical status of the patients with diastolic heart failure. Int J Cardiol 113: 223-228. PMID: 16356564
39. Tsuchida T, Fukuma N, Oikawa K, Kato K, Kato Y, et al. (2007) Relationship between plasma norepinephrine at peak exercise and 123I-MIBG imaging of the heart and lower limbs in heart failure. J Nippon Med Sch 74: 114-122. PMID: 17507788
40. Vinch CS, Aurigemma GP, Hill JC, Gaasch WH, Volturo G, et al. (2003) Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. Am J Cardiol 91: 1140-1143. PMID: 12714167
41. Malpas SC. (2010) Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 90: 513-557. doi: 10.1152/physrev.00007.2009 PMID: 20393193
42. Fagius J, Wallin BG. (1993) Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade. Clin Auton Res 3: 201-205. PMID: 8400820
43. Patel AD, Iskandrian AE. (2002) MIBG imaging. J Nucl Cardiol 9: 75-94. PMID: 11845133
44. Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, et al. (2014) For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? results of a pooled individual patient data meta-analysis. Eur Heart J Cardiovasc Imaging 15: 996-1003. doi: 10.1093/ehjci/jeu044 PMID: 24686260
45. Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, et al. (2013) A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 6: 772-784. doi: 10.1016/j.jcmg.2013.02.007 PMID: 23845574
46. de la Sierra A, Calhoun DA, Vinyoles E, Banegas JR, de la Cruz JJ, et al. (2014) Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance. J Hum Hypertens 28:416-420. doi: 10.1038/jhh.2013.135 PMID: 24401954
47. Rosendorff C. (2009) The chicken and the egg: Sympathetic nervous system activity and left ventricular diastolic dysfunction. Hypertension 53: 108-109. doi: 10.1161/HYPERTENSIONAHA.108.126177 PMID: 19124677
48. Kelm M, Schafer S, Mingers S, Heydthausen M, Vogt M, et al. (1996) Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 14: 1357-1364. PMID: 8934365
49. Borlaug BA, Redfield MM. (2011) Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123: 2006-2014. doi: 10.1161/CIRCULATIONAHA.110.954388 PMID: 21555723
50. Seeland U, Selejan S, Engelhardt S, Muller P, Lohse MJ, et al. (2007) Interstitial remodeling in (beta)1-adrenergic receptor transgenic mice. Basic Res Cardiol 102: 183-193. PMID: 17122889
51. Bronzwaer JG, Paulus WJ. (2009) Diastolic and systolic heart failure: Different stages or distinct phenotypes of the heart failure syndrome? Curr Heart Fail Rep 6: 281-286. PMID: 19948097
52. Marmor A, Green T, Krakuer J, Szucs T, Schneeweiss A. (1989) A single dose of cilazapril improves diastolic function in hypertensive patients. Am J Med 87: 61S-63S. PMID: 2690622
53. Martin-Fernandez B, de las Heras N, Miana M, Ballesteros S, Valero-Munoz M, et al. (2012) Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: Involvement of serum- and glucocorticoid-regulated kinase type 1. Exp Physiol 97: 710-718. doi: 10.1113/expphysiol.2011.063230 PMID: 22327331
54. Miyoshi T, Nakamura K, Oe H, Yoshida M, Akagi S, et al. (2012) Vildagliptin, a dipeptidyl peptidase-4 inhibitor, prevents cardiac hypertrophy and diastolic dysfunction induced by chronic beta-adrenergic stimulation in rat. Eur Heart J 33: 117.
55. Buss SJ, Backs J, Kreusser MM, Hardt SE, Maser-Gluth C, et al. (2006) Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive dahl rats. Endocrinology 147: 2526-2534. PMID: 16439456
56. Leite-Moreira AF. (2006) Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 92: 712-718. PMID: 16614298
57. Levick SP, Murray DB, Janicki JS, Brower GL. (2010) Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension 55: 270-276. doi: 10.1161/HYPERTENSIONAHA.109.142042 PMID: 20048196
58. Murray DR, Prabhu SD, Chandrasekar B. (2000) Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101: 2338-2341. PMID: 10821806
59. Spyrou N, Rosen SD, Fath-Ordoubadi F, Jagathesan R, Foale R, et al. (2002) Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol 40: 1216-1224. PMID: 12383568
60. Paulus WJ, Tschope C. (2013) A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62: 263-271. doi: 10.1016/j.jacc.2013.02.092 PMID: 23684677
61. Grande MT, Pascual G, Riolobos AS, Clemente-Lorenzo M, Bardaji B, et al. (2011) Increased oxidative stress, the renin-angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice. Free Radic Biol Med 51: 1831-1841. doi: 10.1016/j. freeradbiomed.2011.08.014 PMID: 21906672
62. Hubens LE, Verloop WL, Joles JA, Blankestijn PJ, Voskuil M. (2013) Ischemia and reactive oxygen species in sympathetic hyperactivity states: A vicious cycle that can be interrupted by renal denervation? Curr Hypertens Rep 15: 313-320. doi: 10.1007/s11906-013-0367-y PMID: 23754326
63. Rutten FH, Cramer MJ, Paulus WJ. (2012) Heart failure with preserved ejection fraction: Diastolic heart failure. Ned Tijdschr Geneeskd 156: A5315. PMID: 23134752
64. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, et al. (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 14: 803-869. doi: 10.1093/eurjhf/hfs105 PMID: 22828712
65. van Veldhuisen DJ, Cohen-Solal A, Bohm M, Anker SD, Babalis D, et al. (2009) Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data from SENIORS (study of effects of nebivolol intervention on outcomes and rehospitalization in seniors with heart failure). J Am Coll Cardiol 53: 2150-2158. doi: 10.1016/j.jacc.2009.02.046 PMID: 19497441
66. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. (2003) Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 14: 425-430. PMID: 12538743
67. Persson H, Lonn E, Edner M, Baruch L, Lang CC, et al. (2007) Diastolic dysfunction in heart failure with preserved systolic function: Need for objective evidence:Results from the CHARM echocardiographic substudy-CHARMES. J Am Coll Cardiol 49: 687-694. PMID: 17291934
68. Shah RV, Desai AS, Givertz MM. (2010) The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: A systematic review and meta-analysis. J Card Fail 16: 260-267. doi: 10.1016/j.cardfail.2009.11.007 PMID: 20206902
69. Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, et al. (2011) Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: Results of the ex-DHF (exercise training in diastolic heart failure) pilot study. J Am Coll Cardiol 58: 1780-1791. doi: 10.1016/j.jacc.2011.06.054 PMID: 21996391
70. Conraads VM, Metra M, Kamp O, De Keulenaer GW, Pieske B, et al. (2012) Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: Results of the ELANDD study. Eur J Heart Fail 14: 219-225. doi: 10.1093/eurjhf/hfr161 PMID: 22147202
71. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, et al. (2012) Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 59: 901-909. doi: 10.1016/j.jacc.2011.11.034 PMID: 22381425
72. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, et al. (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281. doi: 10.1210/jc.2008-0104 PMID: 18552288
73. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, et al. (2006) Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 114: 2138-2147. PMID: 17088459